BiomX Inc.
PHGE
$4.56
$0.051.11%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -25.68% | -10.24% | 29.24% | 72.24% | 50.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.91% | -22.51% | 28.33% | 61.49% | 35.05% |
| Operating Income | 18.91% | 22.51% | -28.33% | -61.49% | -35.05% |
| Income Before Tax | -195.03% | -234.83% | 55.79% | -164.30% | 222.08% |
| Income Tax Expenses | -- | -60.00% | -80.00% | 200.00% | -- |
| Earnings from Continuing Operations | -195.06% | -235.03% | 55.80% | -164.31% | 221.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -195.06% | -235.03% | 55.80% | -164.31% | 221.96% |
| EBIT | 18.91% | 22.51% | -28.33% | -61.49% | -35.05% |
| EBITDA | 28.52% | 22.89% | -29.32% | -50.06% | -34.70% |
| EPS Basic | -194.28% | -125.23% | 85.04% | 12.01% | 123.73% |
| Normalized Basic EPS | -145.74% | -152.99% | 87.54% | 61.56% | 148.95% |
| EPS Diluted | -194.28% | 89.34% | 85.04% | 2.12% | 123.73% |
| Normalized Diluted EPS | -145.74% | -210.25% | 87.54% | 61.56% | 148.95% |
| Average Basic Shares Outstanding | 91.86% | 332.69% | 270.78% | 200.41% | 170.12% |
| Average Diluted Shares Outstanding | 91.86% | 107.94% | 270.78% | 200.41% | 170.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |